Additionally, a recent study showed that TREM1 plays a role in the inflamed tumor microenvironment, and its inhibition enhances the antitumorigenic effect of anti–PD-1 treatment in murine melanoma, representing an attractive therapeutic target for cancer (53). The gene discussed is TREM1; the disease is cancer.